Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Variability in sensitivity of human lymphocytes to the antiproliferative action of alkylating agents

This is a preview of subscription content, log in to check access.

Literature Cited

  1. 1.

    G. S. Kil'dyshev and Yu. I. Obolentsev, Multidimensional Groupings [in Russian], Moscow (1978).

  2. 2.

    Kim Nam Ir, L. Yu. Telegin, and L. A. Pevnitskii, Byull. Éksp. Biol. Med., No. 4, 79 (1983).

  3. 3.

    O. P. Kirichenko, A. N. Chebotarev, and K. N. Yakovenko, Byull. Éksp. Biol. Med., No. 5, 552 (1976).

  4. 4.

    L. A. Pevnitskii, in: Theoretical Problems in Medical Genetics, A. F. Zakharov, ed. [in Russian], Moscow (1979), p. 115.

  5. 5.

    L. Yu. Telegin, Byull. Éksp. Biol. Med., No. 3, 250 (1979).

  6. 6.

    N. Brock and H.-J. Hohorst, Arzneimittel-Forsch.,13, 1021 (1963).

  7. 7.

    O. B. Friedman and E. Boger, Anal. Chem.,33, 906 (1961).

  8. 8.

    P. Propping, Rev. Physiol. Biochem. Pharmacol.,83, 123 (1978).

  9. 9.

    F. A. Weaver, A. R. Torkelson, W. A. Zygmunt, et al., J. Pharm. Sci.,67, 1009 (1978).

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Veremko, L.N., Telegin, L.Y. & Pevnitskii, L.A. Variability in sensitivity of human lymphocytes to the antiproliferative action of alkylating agents. Bull Exp Biol Med 95, 654–657 (1983). https://doi.org/10.1007/BF00834196

Download citation

Key Words

  • human lymphocytes
  • cyclophosphamide
  • thiophosphamide
  • antiproliferative action